Overfunded defined benefit (DB) pension schemes will be able to share surpluses with members through one-off payments without incurring large tax bills, the government has announced. In the Budget ...
Googlefocused launched yet another coding agent platform, this time focusing on developer teams collaborating to create agents that can execute complex tasks automatically. The platform, called ...
CHICAGO--(BUSINESS WIRE)--In a benchmark study of ComEd, compared to similar utilities, the utility was ranked number one in terms of how low the frequency and duration of outages were for customers.
After Successful Phase A, DARPA to award up to $15M in additional funding to advance QuEra's Stage B R&D plan toward utility-scale neutral-atom quantum computing BOSTON, Nov. 6, 2025 /PRNewswire/ -- ...
The 2025 NFL trade deadline is Tuesday, Nov. 4. The event marks the final opportunity for teams to make substantial changes to the roster, which could ultimately determine the fate of each team's ...
Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...
Rollercoaster Tycoon wasn’t the most fashionable computer game out there in 1999. But if you took a look beneath the pixels—the rickety rides, the crowds of hungry, thirsty, barfing people (and the ...
The NFL has announced disciplinary action for Lions safety Brian Branch, who ignited a postgame fracas by slapping Chiefs wideout JuJu Smith-Schuster on the helmet after Detroit lost 30-17 to Kansas ...
(RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) announced encouraging new data for its investigational gene therapy, DB-OTO, aimed at treating profound genetic hearing loss caused by variants in the ...
Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...
Genetic deficiency of otoferlin, a protein critical to synaptic transmission by the sensory hair cells of the ear, causes congenital deafness. Medicines to treat the condition are lacking; children ...